1.Research Progress of Pharmacological Intervention of Sevoflurane-induced Nerve Injury in the Developing Brain.
Acta Academiae Medicinae Sinicae 2021;43(3):462-468
Sevoflurane is one of the most commonly used inhaled anesthetics in obstetric and pediatric general anesthesia.According to related literature,this article reviews major possible mechanisms including myelin formation damage,nerve inflammation,cell apoptosis,oxidative stress,inhibition of histone acetylation,synapsis and receptor changes of sevoflurane-induced neurotoxicity in animal experiments.Furthermore,we summarize the neuroprotection effects and functioning mechanisms of anti-anemia medicine,plant-based drugs,alpha 2 adrenoceptor agonists and others,aiming to provide a basis for the brain protection of fetuses and infants during the perioperative period.
Anesthetics, Inhalation/adverse effects*
;
Animals
;
Apoptosis
;
Brain
;
Child
;
Female
;
Humans
;
Methyl Ethers
;
Neuroprotective Agents/therapeutic use*
;
Oxidative Stress
;
Pregnancy
;
Sevoflurane
2.Kidney Function in Living Donors Undergoing Nephrectomy by Sevoflurane or Desflurane Anesthesia.
Min Soo KIM ; Jeong Rim LEE ; Myoung Soo KIM ; Sung Yeon HAM ; Seung Ho CHOI
Yonsei Medical Journal 2013;54(5):1266-1272
PURPOSE: Although there is no clinical evidence of nephrotoxicity with the volatile anesthetics currently used in general anesthesia, a better agent should be needed in terms of preserving postoperative renal function in living kidney donors who have only single remaining kidney. The purpose of the current retrospective, single-center study was to evaluate and compare renal function of living kidney donors after nephrectomy under either sevoflurane or desflurane anesthesia. MATERIALS AND METHODS: From January 2006 through December 2011, a total of 228 donors undergoing video assisted minilaparotomy surgery nephrectomy for kidney donation were retrospectively enrolled in the current study. The donors were categorized into a sevoflurane group or desflurane group based on the type of volatile anesthetic used. We collected laboratory data from the patients preoperatively, immediately after the operation, on the first postoperative day and on the third postoperative day. We also compared renal function of the kidney donors after donor nephrectomy by comparing creatinine level and estimated glomerular filtration rate (eGFR). RESULTS: The decrease in renal function after surgery in both groups was the most prominent on the first postoperative day. There were no significant differences between the two groups in postoperative changes of creatinine or eGFR. CONCLUSION: Sevoflurane and desflurane can be used safely as volatile anesthetics in donors undergoing nephrectomy.
Adult
;
Anesthesia, General/methods
;
Anesthetics, Inhalation/adverse effects/*therapeutic use
;
Female
;
Humans
;
Isoflurane/adverse effects/*analogs & derivatives/therapeutic use
;
Kidney/*physiology
;
Kidney Function Tests
;
*Kidney Transplantation
;
*Living Donors
;
Male
;
Methyl Ethers/adverse effects/*therapeutic use
;
*Nephrectomy
;
Postoperative Complications
;
Retrospective Studies
3.Effect-Site Concentration of Remifentanil for Minimizing Cardiovascular Changes by Inhalation of Desflurane.
Hee Jin JEONG ; Hee Jung BAIK ; Jong Hak KIM ; Youn Jin KIM ; Jae Hyon BAHK
Yonsei Medical Journal 2013;54(3):739-746
PURPOSE: This study aims to investigate the most appropriate effect-site concentration of remifentanil to minimize cardiovascular changes during inhalation of high concentration desflurane. MATERIALS AND METHODS: Sixty-nine American Society of Anesthesiologists physical status class I patients aged 20-65 years were randomly allocated into one of three groups. Anesthesia was induced with etomidate and rocuronium. Remifentanil was infused at effect-site concentrations of 2, 4 and 6 ng/mL in groups R2, R4 and R6, respectively. After target concentrations of remifentanil were reached, desflurane was inhaled to maintain the end-tidal concentration of 1.7 minimum alveolar concentrations for 5 minutes (over-pressure paradigm). The systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), heart rate (HR) and end-tidal concentration of desflurane were measured for 5 minutes. RESULTS: The end-tidal concentration of desflurane increased similarly in all groups. The SBP, DBP, MAP and HR within group R4 were not significantly different as compared with baseline values. However, measured parameters within group R2 increased significantly 1-3 minutes after desflurane inhalation. The MAP within group R6 decreased significantly at 1, 2, 4, and 5 minutes (p<0.05). There were significant differences in SBP, DBP, MAP and HR among the three groups 1-3 minutes after inhalation (p<0.05). The incidence of side effects such as hyper- or hypo-tension, and tachy- or brady-cardia in group R4 was 4.8% compared with 21.8% in group R2 and 15.0% in group R6. CONCLUSION: The most appropriate effect-site concentration of remifentanil for blunting hemodynamic responses by inhalation of high concentration desflurane is 4 ng/mL.
Adult
;
Aged
;
Androstanols/adverse effects/pharmacology
;
Anesthetics/adverse effects/pharmacology
;
Anesthetics, Inhalation/adverse effects/*pharmacology
;
Blood Pressure/drug effects
;
Etomidate/adverse effects/pharmacology
;
Female
;
Heart/*drug effects
;
Heart Rate/drug effects
;
Humans
;
Isoflurane/adverse effects/*analogs & derivatives/pharmacology
;
Male
;
Middle Aged
;
Piperidines/adverse effects/*therapeutic use
;
Protective Agents/adverse effects/*therapeutic use
4.Effect of Propofol and Desflurane on Immune Cell Populations in Breast Cancer Patients: A Randomized Trial.
Jae Hee WOO ; Hee Jung BAIK ; Chi Hyo KIM ; Rack Kyung CHUNG ; Dong Yeon KIM ; Guie Yong LEE ; Eun Hee CHUN
Journal of Korean Medical Science 2015;30(10):1503-1508
Several factors can affect the perioperative immune function. We evaluated the effect of propofol and desflurane anesthesia on the surgery-induced immune perturbation in patients undergoing breast cancer surgery. The patients were randomly assigned to receive propofol (n = 20) or desflurane (n = 20) anesthesia. The total and differential white blood cell counts were determined with lymphocyte subpopulations before and 1 hr after anesthesia induction and at 24 hr postoperatively. Plasma concentrations of interleukin (IL)-2 and IL-4 were also measured. Both propofol and desflurane anesthesia preserved the IL-2/IL-4 and CD4+/CD8+ T cell ratio. Leukocytes were lower in the propofol group than in the desflurane group at 1 hr after induction (median [quartiles], 4.98 [3.87-6.31] vs. 5.84 [5.18-7.94] 10(3)/microL) and 24 hr postoperatively (6.92 [5.54-6.86] vs. 7.62 [6.22-9.21] 10(3)/microL). NK cells significantly decreased 1 hr after induction in the propofol group (0.41 [0.34-0.53] to 0.25 [0.21-0.33] 10(3)/microL), but not in the desflurane group (0.33 [0.29-0.48] to 0.38 [0.30-0.56] 10(3)/microL). Our findings indicate that both propofol and desflurane anesthesia for breast cancer surgery induce a favorable immune response in terms of preservation of IL-2/IL-4 and CD4+/CD8+ T cell ratio in the perioperative period. With respect to leukocytes and NK cells, desflurane anesthesia is associated with less adverse immune responses than propofol anesthesia during surgery for breast cancer. (Clinical trial registration at https://cris.nih.go.kr/cris number: KCT0000939)
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Anesthesia/adverse effects
;
Anesthetics, Inhalation/*therapeutic use
;
Anesthetics, Intravenous/*therapeutic use
;
Breast Neoplasms/immunology/*surgery
;
*CD4-CD8 Ratio
;
Female
;
Humans
;
Interleukin-2/blood
;
Interleukin-4/blood
;
Isoflurane/*analogs & derivatives/therapeutic use
;
Middle Aged
;
Postoperative Period
;
Propofol/*therapeutic use
;
Young Adult